Scenario 1: New patient, first injection Sarah just received her first vial of compounded tirzepatide at 10 mg/mL
10.3389/fphar.2021.632295 Summary Keywords gastric pentadecapeptide BPC 157, primary abdominal compartment syndrome, rats, brain edema, lung edema Citation Tepes M, Gojkovic S, Krezic I, Zizek H, Vranes H, Madzar Z, Santak G, Batelja L, Milavic M, Sikiric S, Kocman I, Simonji K, Samara M, Knezevic M, Barisic I, Lovric E, Strbe S, Kokot A, Sjekavica I, Kolak T, Skrtic A, Seiwerth S, Boban Blagaic A and Sikiric P (2021) Stable Gastric Pentadecapeptide BPC 157 Therapy for Primary Abdominal Compartment Syndrome in Rats
Most researchers report needing at least four weeks of consistent daily use before noticing visible improvements
HSA and FSA accounts cover PlexusDx tirzepatide, making personalized therapy accessible to more patients
T/&se de Paris;1907
Potential for New Indications As evidence builds, its possible that GLP-1s will be approved for new uses beyond diabetes and weight management, including for anxiety and alcohol dependence